ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Forma Therapeutics Holdings Inc

Forma Therapeutics Holdings Inc (FMTX)

20.01
0.00
(0.00%)
At close: July 31 4:00PM
20.01
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
20.01
Bid
19.98
Ask
19.40
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
20.01
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

FMTX Latest News

Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease

The “Believe it!” Campaign Will be Featured on TV Networks and Radio Stations Across the U.S., Driving Viewers to SCDBelieveIT.org The Sickle Cell Disease Association of America, Inc. (SCDAA...

Forma Therapeutics Shares Surge on Takeover by Novo Nordisk

By Colin Kellaher Shares of Forma Therapeutics Holdings Inc. took flight Thursday after the clinical-stage biopharmaceutical company agreed to be acquired by Denmark's Novo Nordisk AS for...

Novo Nordisk to Buy Forma Therapeutics for $1.1 Billion

By Colin Kellaher Novo Nordisk AS on Thursday said it agreed to buy clinical-stage biopharmaceutical company Forma Therapeutics Holdings Inc. for about $1.1 billion in a deal that expands the...

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for...

Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Announced analyses from Phase I study of etavopivat in sickle cell disease indicated reduction of reported pain-related adverse events, supporting potential to reduce vaso-occlusive...

Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid...

Forma Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on August 5, 2022

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease (SCD), prostate cancer and other rare hematologic diseases and cancers...

Forma Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other rare hematologic diseases and cancers, today...

Forma Therapeutics Announces Appointment of New Executive Team Members

Agustín Melián, M.D. to be named Executive Vice President, Head of Research and Development and Linea Aspesi to be named Senior Vice President, Chief Human Resources Officer Appointments...

Forma Therapeutics Announces Presentations at Upcoming Hematology Conferences

Updated results from the completed Phase 1 study of etavopivat in patients with sickle cell disease (SCD) Study design for the Phase 2 Gladiolus Study of etavopivat in patients with...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IMRXImmuneering Corporation
$ 1.69
(49.56%)
5.67M
MDJHMDJM Ltd
$ 2.05
(27.33%)
300.75k
CDNACareDx Inc
$ 24.20
(21.06%)
67.31k
KXINKaixin Holdings
$ 0.134801
(20.90%)
4.12M
VEROVenus Concept Inc
$ 0.80
(14.24%)
1.26k
ALXOALX Oncology Holdings Inc
$ 3.44
(-28.33%)
3.69M
ATECAlphatec Holdings Inc
$ 8.02
(-20.59%)
323.16k
UDMYUdemy Inc
$ 7.63
(-17.42%)
105.04k
LABStandard BioTools Inc
$ 1.89
(-15.63%)
43.25k
FAASDigiAsia Corporation
$ 1.60
(-14.89%)
3.38k
NVDANVIDIA Corporation
$ 120.45
(2.93%)
20.53M
METAMeta Platforms Inc
$ 507.01
(6.78%)
6.6M
CTNTCheetah Net Supply Chain Service Inc
$ 0.299
(9.24%)
6.01M
IMRXImmuneering Corporation
$ 1.69
(49.56%)
5.67M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.86%)
4.72M

Discussion

View Full Feed
mrwrn2010 mrwrn2010 5 minutes ago
Can you tell me the drugs that are pending launch and what the market value is of those drugs?
ELTP
SCAMBUSTERKING SCAMBUSTERKING 5 minutes ago
Imagine being happy he moved the date back from Aug 1 to Aug 12th and say "he's back" 😂
HPIL
I-Glow I-Glow 5 minutes ago
I was talking with a securities attorney yesterday and I asked them about hijacked shells. They told me that someone gained custodianship of the shell and the 15c2-11 had been removed - it would be almost impossible for FINRA to process a new 15c2-11.

All of the SSM hijacked shells ex
WNFT
dragoon76 dragoon76 5 minutes ago
I thought there was a gap that needed to be filled in high 80's. Not surprised it's come back down.
COOP
J2003 J2003 5 minutes ago
Nice close today! High of month!
BEGI
LORTAP KCOTS LORTAP KCOTS 5 minutes ago
Well they aren’t spending anything on their marketing, those cheap looking product photos have to be free
EDXC
EL Sueno EL Sueno 6 minutes ago
Re Coo Breeze Very good point Climb 2 Top!??
USMJ
blownaccount9 blownaccount9 6 minutes ago
Yeah I hate that he is in on this as well. That snake got me once, but thankfully never fell for his SPAC antics.
FNMA
newmedman newmedman 6 minutes ago
check out the feed if you're able

I'm looking for the old park equipment and bad slides at this point.

https://x.com/Super70sSports/status/1767336516647350466
k9uwa k9uwa 6 minutes ago
Traffic in Miami is light except for Go To and Go Home from Work. For REAL traffic in Miami you should be there Jan, Feb, March. It starts picking up in late October and isn't done until end of April. They call them "Snowbirds" Looks like we are level so far in afterhours.
John k9uwa
AVXL
NASDAQ2020 NASDAQ2020 6 minutes ago
Why do you care if you’re selling at 24:?
ELTP
janice shell janice shell 7 minutes ago
Keeping my fingers crossed that it's next to a couple of sunny side eggs with some toast or biscuits.

My feelings exactly. But the poor ham did get its own back on its torturer. It didn't let her cut it, though she'd assured her viewers that it would just "fall apart".
Tomdontworry Tomdontworry 7 minutes ago
Evolus is in 14k accounts vs 3.5k accounts for Revance. Botox decreased guidance by 100m and Evolus increased guidance by 5m. Cant wait to see Fooley’s results.
RVNC
Stock_Barber Stock_Barber 7 minutes ago
Wow... you better take out a 3rd mortgage on the house to buy all that you can!

Everyone who holds stock will be multi-millionaires and can retire immediately!


https://media3.giphy.com/media/3o6MbmYoDGwmpadTPO/giphy.gif?cid=6c09b952h5peeddp6hx1xpzll2xkwgzxxpsisb
DBMM
Royal Dude Royal Dude 7 minutes ago
Finally AZ, To be more specific beginning October 22nd then quarterly each January 22, 2025 and and on.......

"The fixed-to-floating rate notes due 2028, which we refer to as the 2028 fixed-to-floating rate notes, will mature on July 22, 2028. The 2028 fixed-to-floating rate notes wil
COOP
bull runs bull runs 7 minutes ago
How many wars did we have under Trump? Lmao. With every new post you show your true colors. 😂🤣. You’re a weak leftist liberal. You’re too ignorant to understand what made what you love most. Canada is pretty darn close to being the next France. If not already, you will have your
williamssc williamssc 8 minutes ago
If I recall correctly FDA approved Donepezil head of it's P3 trial finishing. And now it's being used as placebo.
AVXL
fuagf fuagf 8 minutes ago
rooster, Seriously can't you read??? Though since Americans have done those ratings i don't blame you for laughing.

You would be being unfair to many who don't support Trump, still i get why you could be laughing even if you could read better.
ProLiberty ProLiberty 9 minutes ago
From Transcript: Aaron D. Berg -- President and Chief Executive Officer

Yes. Thanks, Mark. And first of all, thanks again to all the investors who submitted these questions. We greatly appreciate it.

It's important to keep in mind that while the loss of the commercial
PBM
FinsDontRule FinsDontRule 9 minutes ago
Me neither. I bet 80% of these small cap companies go down over time too. At least 80
INM
Jack_Herer Jack_Herer 10 minutes ago
Love the optimism here.
But it's still a mining con.
With the added dimension of uber wealthy royals from afar. Kinda like the old Nigerian prince 419 letter scam...

https://investorshub.advfn.com/uimage/uploads/2024/7/27/wsqrftwain.jpg
HIRU
jimr1717 jimr1717 10 minutes ago
Yes! Slap that ask! Warning! This security is eligible for Unsolicited Quotes Only
This stock is not eligible for proprietary broker-dealer quotations. All quotes in this stock reflect unsolicited customer orders. Unsolicited-Only stocks have a higher risk of wider spreads, increased volatil
BABL
fuagf fuagf 12 minutes ago
Thanks. That's good enough to take it as true until proved otherwise. It's odd that on a search i don't come up with it. Umm, i didn't come up with Noel Casler either so perhaps my searches are governed too much by greater powers. I have tried other browsers with no better results. Shooks. Thanks ag
dstock07734 dstock07734 12 minutes ago
Cashed out at $8 and now start loading $0.4! That's great! Congrats!
Only this time don't sell any before it hits $13.
NWBO
Jagman5 Jagman5 14 minutes ago
No and neither does the company. The S-4 must be made effective and then they can schedule the two shareholder meetings that must be held. They are working with / waiting on the SEC to make it effective.

$RXMD
RXMD